Brief: scPharmaceuticals Q1 Revenue USD 11.752 Million Vs. IBES Estimate USD 11.6 Million
May 14 (Reuters) - scPharmaceuticals Q1 operating expenses USD 29.509 million. Q1 income from operations USD -17.757 million vs. IBES estimate USD -16.2 million Q1 basic EPS USD -0.37 Q1 net income USD -19.742 million vs. IBES estimate USD -16.8 million